JTO Clinical and Research Reports (Aug 2022)

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

  • Shannon S. Zhang, MD,
  • Sai-Hong Ignatius Ou, MD, PhD

Journal volume & issue
Vol. 3, no. 8
p. 100358

Abstract

Read online

No abstracts available.